Cdk2-dependent phosphorylation of p21 regulates the role of Cdk2 in cisplatin cytotoxicity

Rawad Hodeify, Adel Tarcsafalvi, Judit Megyesi, Robert L. Safirstein, Peter M. Price

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cisplatin cytotoxicity is dependent on cyclin-dependent kinase 2 (Cdk2) activity in vivo and in vitro. We found that an 18-kDa protein identified by mass spectrometry as p21WAF1/Cip1 was phosphorylated by Cdk2 starting 12 h after cisplatin exposure. The analysis showed it was phosphorylated at serine 78, a site not previously identified. The adenoviral transduction of p21 before cisplatin exposure protects from cytotoxicity by inhibiting Cdk2. Although cisplatin causes induction of endogenous p21, the protection is inefficient. We hypothesized that phosphorylation of p21 at serine 78 could affect its role as a Cdk inhibitor, and thereby lessen its ability to protect from cisplatin cytotoxicity. To investigate the effect of serine 78 phosphorylation on p21 activity, we replaced serine 78 with aspartic acid, creating the phosphomimic p21S78D. Mutant p21S78D was an inefficient inhibitor of Cdk2 and was inefficient at protecting TKPTS cells from cisplatininduced cell death. We conclude that phosphorylation of p21 by Cdk2 limits the effectiveness of p21 to inhibit Cdk2, which is the mechanism for continued cisplatin cytotoxicity even after the induction of a protective protein.

Original languageEnglish
Pages (from-to)1171-1179
Number of pages9
JournalAmerican Journal of Physiology - Renal Physiology
Volume300
Issue number5
DOIs
Publication statusPublished - 1 May 2011
Externally publishedYes

    Fingerprint

Keywords

  • Cell death

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this